Yousif Capital Management LLC Sells 5,736 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Yousif Capital Management LLC cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 113,469 shares of the healthcare conglomerate’s stock after selling 5,736 shares during the quarter. UnitedHealth Group makes up approximately 0.7% of Yousif Capital Management LLC’s portfolio, making the stock its 13th largest holding. Yousif Capital Management LLC’s holdings in UnitedHealth Group were worth $59,738,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Wellington Management Group LLP grew its holdings in shares of UnitedHealth Group by 2.1% in the third quarter. Wellington Management Group LLP now owns 25,220,234 shares of the healthcare conglomerate’s stock worth $12,715,790,000 after purchasing an additional 527,526 shares during the last quarter. Northern Trust Corp lifted its position in UnitedHealth Group by 3.6% during the third quarter. Northern Trust Corp now owns 9,787,768 shares of the healthcare conglomerate’s stock valued at $4,934,895,000 after buying an additional 341,749 shares during the period. Bank of New York Mellon Corp boosted its stake in UnitedHealth Group by 2.2% in the 3rd quarter. Bank of New York Mellon Corp now owns 8,242,282 shares of the healthcare conglomerate’s stock worth $4,155,676,000 after purchasing an additional 180,331 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its stake in UnitedHealth Group by 0.5% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 5,843,207 shares of the healthcare conglomerate’s stock worth $2,937,976,000 after purchasing an additional 27,127 shares in the last quarter. Finally, Sanders Capital LLC boosted its stake in UnitedHealth Group by 6.5% in the 3rd quarter. Sanders Capital LLC now owns 5,757,410 shares of the healthcare conglomerate’s stock worth $2,902,829,000 after purchasing an additional 352,710 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Down 1.0 %

NYSE UNH traded down $4.86 during trading hours on Tuesday, hitting $486.37. 3,645,655 shares of the company were exchanged, compared to its average volume of 4,543,351. The company has a 50 day moving average of $487.49 and a two-hundred day moving average of $514.76. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $554.70. The firm has a market cap of $448.40 billion, a price-to-earnings ratio of 29.73, a PEG ratio of 1.38 and a beta of 0.54.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. The firm had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The business’s revenue was up 8.6% on a year-over-year basis. During the same period in the prior year, the firm earned $6.26 EPS. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were paid a $1.88 dividend. This represents a $7.52 annualized dividend and a yield of 1.55%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s payout ratio is currently 45.97%.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on UNH. Truist Financial reissued a “buy” rating and issued a $600.00 target price on shares of UnitedHealth Group in a research report on Wednesday, April 17th. Royal Bank of Canada dropped their price target on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a research note on Wednesday, April 17th. Morgan Stanley dropped their price target on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a research note on Friday, April 5th. StockNews.com downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, April 18th. Finally, Erste Group Bank reiterated a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. Four analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $570.05.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by company insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.